Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fuzheng Huayu tablet after Kasai surgery in biliary atresia
ChiCTR2000037187Phase 4Recruiting
- Sponsor
- Shanghai Children's Hospital
- Start
- Oct 2020
- Countries
- 1
01
Overview
Phase 4, randomised trial of fuzheng huayu in biliary atresia (2 arms), sponsored by Shanghai Children's Hospital. Primary endpoint: Jaundice clearance rate at 6 months after surgery. Started Oct 2020; status: recruiting.
02
Drugs
fuzheng huayu
03
Conditions
biliary atresia
Beyond the preview
Go deeper on ChiCTR2000037187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000037187.